Skip to main content

Medication Abuse

0
Pipeline Programs
1
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
6 programs
Clinical Decision SupportN/A1 trial
Medications for Opioid Use Disorder Pathway Clinical Decision SupportN/A1 trial
Naloxone Co-prescribing Clinical Decision SupportN/A1 trial
Opioid Tapering Pathway Clinical Decision SupportN/A1 trial
Opioid Transitions Clinical Decision SupportN/A1 trial
+1 more programs
Active Trials
NCT04918355Completed3,635Est. Nov 2023
NCT06526286Not Yet Recruiting200,000Est. May 2027
NCT06271668Enrolling By Invitation200,000Est. Apr 2026
+3 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Colorado TherapeuticsOpioid Tapering Pathway Clinical Decision Support
Colorado TherapeuticsMedications for Opioid Use Disorder Pathway Clinical Decision Support
Colorado TherapeuticsOpioid Transitions Clinical Decision Support
Colorado TherapeuticsPDMP Check CDS
Colorado TherapeuticsNaloxone Co-prescribing Clinical Decision Support
Colorado TherapeuticsClinical Decision Support

Clinical Trials (6)

Total enrollment: 893,506 patients across 6 trials

NCT06527079Colorado TherapeuticsOpioid Tapering Pathway Clinical Decision Support

Evaluation of Clinical Decision Support in Opioid Tapering

Start: Aug 2026Est. completion: Jun 2027200,000 patients
N/ANot Yet Recruiting
NCT06526286Colorado TherapeuticsMedications for Opioid Use Disorder Pathway Clinical Decision Support

Clinical Decision Support to Increase Use of Medications for Opioid Use Disorder

Start: Jun 2026Est. completion: May 2027200,000 patients
N/ANot Yet Recruiting
NCT06527040Colorado TherapeuticsOpioid Transitions Clinical Decision Support

Clinical Decision Support for Safety of Opioid Transitions

Start: Jun 2026Est. completion: Jun 2027200,000 patients
N/ANot Yet Recruiting
NCT06215560Colorado TherapeuticsPDMP Check CDS

A Prospective Evaluation of Colorado's New Statutory PDMP Mandates: Compliance and Patient Outcomes

Start: Jan 2025Est. completion: Jan 202689,871 patients
N/ACompleted
NCT06271668Colorado TherapeuticsNaloxone Co-prescribing Clinical Decision Support

Clinical Decision Support to Improve System Naloxone Co-prescribing

Start: Jul 2024Est. completion: Apr 2026200,000 patients
N/AEnrolling By Invitation
NCT04918355Colorado TherapeuticsClinical Decision Support

A Health System Wide Evaluation of Clinical Decision Support Tools to Improve PDMP Utilization and Patient Outcomes

Start: Feb 2021Est. completion: Nov 20233,635 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.